This content is machine translated Sponsored Content: Atopic dermatitis: Roadshow 2024 Better standard of care through joint decision-making The first Swiss Atopic Dermatitis (AD) Roadshow took place at the beginning of February 2024. AD expert Prof. Jonathan Silverberg from the George Washington University School of Medicine and Health…
View Post 5 min This content is machine translated Endometrial Cancer Dostarlimab in everyday clinical practice: initial experiences with diagnostics and therapy Patients with primary advanced or recurrent endometrial cancer have a poor prognosis, particularly in the long-term course of treatment with carboplatin plus paclitaxel. This can be significantly improved with the…
View Post 4 min This content is machine translated Light skin cancer Prevention and early detection of an underestimated disease Light skin cancers are the most common cancers in fair-skinned people. They occur in at least 200 out of 100,000 people per year in Germany, especially basal cell carcinoma and…
View Post 5 min This content is machine translated Atopic dermatitis in the era of precision medicine Research into molecular biomarkers opens up new horizons The identification and study of molecular biomarkers may help to dissect the complex phenotype of atopic dermatitis into subphenotypes. A long-term goal of this translational research is the stratification and…
View Post 1 min This content is machine translated Podcast JAK inhibitors in inflammatory rheumatic diseases. Thanks to the development of advanced therapies, the goal of remission is within reach for more and more patients with inflammatory rheumatic diseases [1]. In the following podcast, Prof. Stephan…
View Post 5 min This content is machine translated Atopic dermatitis: system therapy Patient-centered care as the key to successful treatment The therapeutic landscape in the field of atopic dermatitis is changing. The spectrum of biologics and JAK inhibitors has expanded. Study data attest to the high efficacy of all currently…
View Post 3 min This content is machine translated Video interview with two professionals Individualized therapy decisions in osteoporosis The chronic metabolic disease osteoporosis is particularly prevalent among postmenopausal women and can lead to severe health complications [1]. Judith Everts-Graber, MD, and Prof. Serge Ferrari discuss in a video interview…
View Post 4 min This content is machine translated Pilot project in Switzerland OnlineDoctor offers digital prescriptions with electronic signature by dermatologist Especially when skin problems occur acutely, long waiting times for an appointment at a dermatological practice are a problem for many sufferers. OnlineDoctor – the leading provider of teledermatology in…
View Post 9 min This content is machine translated Interview with Prof. Dr. med. Gerd Burmester “With the JAK inhibitors, we can get much more out of them for our patients” Oral Janus kinase inhibitors (JAKi) have been expanding the treatment landscape for inflammatory rheumatoid diseases for several years. In the following interview, Prof. Dr. med. Gerd Burmester explains what this…
View Post 11 min This content is machine translated Interview on World Rheumatism Day “When those affected forget about the disease in their daily lives, it’s a particularly nice moment for us physicians.” Every year on October 12 is World Rheumatism Day. This was launched in 1996 by the international federation of self-help associations of rheumatism sufferers, “Arthritis and Rheumatism International (ARI)”. When…
View Post 1 min This content is machine translated Relapsed/refractory chronic lymphocytic leukemia The treatment of R/R CLL: guidelines, studies and case reports. The development of new, targeted substances can replace classic chemotherapies with more tolerable approaches 1 . In this webcast, Marc Heizmann, MD, Senior Physician Hematology and Transfusion Medicine at the Cantonal…
